Full-Time

Senior Product Manager

IT Security OCM

Confirmed live in the last 24 hours

Exelixis

Exelixis

1,001-5,000 employees

Develops and commercializes cancer therapies

Compensation Overview

$138k - $196.5k/yr

+ Bonus + Stock Purchase Opportunity + Long-term Incentives + Vacation Days + Paid Holidays + Sick Days

Senior, Expert

Alameda, CA, USA

This is a work from office job at the Exelixis Corporate Headquarters in Alameda, CA.

Category
Technical Product Management
Product
Required Skills
Product Management
Risk Management
Data Analysis
Requirements
  • Bachelor’s degree in related discipline with a minimum of 9 years of related application experience; or Master’s degree in related discipline with a minimum of 7 years of related application experience.
  • Experience in the pharmaceutical and biotech industries is an advantage but not a requirement.
  • Strategic and practical application in today’s institutions, corporate and/or government is key.
  • Security Subject Matter Expertise: Intermediate knowledge in Risk Management, Data Protection, and Identity & Access Management.
  • Learning & Engagement Expert: Advanced understanding of learning theories and instructional design principles.
Responsibilities
  • Effectively collaborate with stakeholders to understand the organizational requirements, both risk/threat issues and performance concerns.
  • Defines clear and measurable learning outcomes to guide the design process and drive learning development.
  • Chooses appropriate instructional methods based on learning objectives and learner characteristics.
  • Develops and/or gathers relevant resources to inform instruction.
  • Creates and/or purchases engaging and effective learning materials that align with the learning objectives and instructional strategies.
  • Incorporates multimedia elements to enhance engagement and learning when possible.
  • Utilizes and/or supports eLearning authoring tools and software to develop interactive and engaging learning experiences.
  • Manage the training project effectively, ensuring deadlines are met and resources are utilized efficiently.
  • Chooses appropriate platforms for delivering learning experiences.
  • Plans and manages the implementation of the learning program, ensuring that it reaches the target audience and is delivered effectively.
  • Provides technical support and ongoing assistance to learners during the deployment of the training.
  • Gathers feedback from learners and stakeholders to assess the effectiveness of the learning experience.
  • Analyzes data and metrics to identify areas for improvement and refine the learning materials and delivery methods.
  • Uses evaluation results to revise and refine the learning program for ongoing improvement.
Desired Qualifications
  • Affiliation to Learning and OCM institutions or groups is a plus.

Exelixis develops and commercializes medicines specifically for cancer treatment. The company focuses on creating therapies that target various biological pathways and can be used in combination with other treatments, which helps to enhance their effectiveness and tolerability. Exelixis primarily addresses the needs of patients with advanced cancers, such as renal cell carcinoma, by conducting extensive research, clinical trials, and obtaining regulatory approvals for new drugs. Unlike many competitors, Exelixis emphasizes a combination approach in its therapies, which can lead to better patient outcomes. The goal of Exelixis is to improve the quality of life for cancer patients and provide them with hope for remission through its drug development efforts.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

1994

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships can expand Exelixis' pipeline and market reach.
  • AI-driven drug discovery accelerates identification of novel cancer targets for Exelixis.
  • Telemedicine improves patient monitoring, enhancing outcomes of Exelixis' therapies.

What critics are saying

  • Generic competition may reduce market share for CABOMETYX®.
  • Reliance on future drug approvals may not meet expectations.
  • Need for additional funding may indicate financial pressures.

What makes Exelixis unique

  • Exelixis focuses on combination regimens for advanced cancer treatment.
  • The company targets multiple pathways to create effective and durable cancer therapies.
  • Exelixis has a strong pipeline with four molecules in preclinical stages.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Employee Stock Purchase Plan

Company News

Medical Update Online
Mar 28th, 2025
Exelixis to present preclinical data for four pipeline molecules at AACR 2025

Exelixis to present preclinical data for four pipeline molecules at AACR 2025.

Defense World
Mar 9th, 2025
Proficio Capital Partners LLC Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)

Proficio Capital Partners LLC makes new investment in Exelixis, Inc. (NASDAQ:EXEL).

Stock Titan
Feb 13th, 2025
Exelixis to Participate in the Citi 2025 Virtual Oncology Leadership Summit

Exelixis to participate in the Citi 2025 Virtual Oncology Leadership Summit.

MarketBeat
Jan 7th, 2025
Range Financial Group LLC Invests $994,000 in Exelixis, Inc. (NASDAQ:EXEL)

Range Financial Group LLC invests $994,000 in Exelixis, Inc. (NASDAQ:EXEL).

Stock Titan
Jan 6th, 2025
Exelixis to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025

Exelixis to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.